Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Morning Bell 4 July

Sophia Mavridis
July 4, 2022

Weekly Wrap 1 July

Sophia Mavridis
July 1, 2022

Morning Bell 30 June

Paulina Peters
June 30, 2022

Morning Bell 29 June

Sophia Mavridis
June 29, 2022

Morning Bell 28 June

Paulina Peters
June 28, 2022

Morning Bell 27 June

Sophia Mavridis
June 27, 2022

Weekly Wrap 24 June

Sophia Mavridis
June 24, 2022

Morning Bell 23 June

Paulina Peters
June 23, 2022

Morning Bell 22 June

Sophia Mavridis
June 22, 2022

Morning Bell 21 June

Paulina Peters
June 21, 2022